Literature DB >> 16981139

Oxidative stress in young Zucker rats with impaired glucose tolerance is diminished by acarbose.

P Rösen1, A Osmers.   

Abstract

AIMS/HYPOTHESIS: There is evidence that acarbose reduces the risk for development of diabetes and cardiovascular complications. The mechanism underlying the vasculoprotective effect is however not known. We hypothesized that vasculoprotection observed by acarbose may be the consequence of a diminished generation of oxidative stress.
METHODS: Lean and obese Zucker rats received a diet containing 10% sucrose for 7 days. A part of the rats was treated with acarbose (15 mg/kg/day in chow). Blood glucose, plasma insulin, lipid peroxides, and as a more specific marker of oxidative stress, 8-isoprostanes, were analyzed. As cellular markers of oxidative stress we determined the activities of mitochondrial aconitase and NADPH-oxidase in aorta, heart, and kidney. In addition, poly(ADP-ribose) polymerase activity (PARP) was measured in aorta.
RESULTS: Sucrose feeding of obese Zucker rats resulted in increased blood glucose levels, plasma insulin, lipid peroxides and 8-isoprostanes. Mitochondrial aconitase was reduced; the activities of NAPDH-oxidase and PARP were enhanced. Treatment of obese Zucker rats with acarbose largely prevented these changes, whereas it had no effect in lean sucrose fed rats.
CONCLUSION: Specifically in obese Zucker rats sucrose feeding is associated with an increased oxidative stress. The data provide IN VIVO evidence that mitochondria play a role in the generation of reactive oxygen species (ROS) in insulin resistant, hyperglycaemic states. Activation of PARP by ROS may be an important mediator of vascular dysfunction in insulin resistance. Treatment with acarbose is helpful to prevent the increase in oxidative stress and vascular dysfunction induced by hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981139     DOI: 10.1055/s-2006-950397

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

1.  The role of mitochondrial DNA damage at skeletal muscle oxidative stress on the development of type 2 diabetes.

Authors:  Julia Matzenbacher Dos Santos; Denise Silva de Oliveira; Marcos Lazaro Moreli; Sandra Aparecida Benite-Ribeiro
Journal:  Mol Cell Biochem       Date:  2018-04-20       Impact factor: 3.396

Review 2.  Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs.

Authors:  Carolin Thomas; Lia Wurzer; Ernst Malle; Michael Ristow; Corina T Madreiter-Sokolowski
Journal:  Front Aging       Date:  2022-06-14

3.  Short-and long-term administration of imeglimin counters cardiorenal dysfunction in a rat model of metabolic syndrome.

Authors:  Marianne Lachaux; Matthieu Soulié; Mouad Hamzaoui; Anaëlle Bailly; Lionel Nicol; Isabelle Rémy-Jouet; Sylvanie Renet; Cathy Vendeville; Pascale Gluais-Dagorn; Sophie Hallakou-Bozec; Christelle Monteil; Vincent Richard; Paul Mulder
Journal:  Endocrinol Diabetes Metab       Date:  2020-04-16

Review 4.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats.

Authors:  Giancarlo Aldini; Marica Orioli; Giuseppe Rossoni; Federica Savi; Paola Braidotti; Giulio Vistoli; Kyung-Jin Yeum; Gianpaolo Negrisoli; Marina Carini
Journal:  J Cell Mol Med       Date:  2010-06-01       Impact factor: 5.310

6.  The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure.

Authors:  Najah Harouki; Lionel Nicol; Isabelle Remy-Jouet; Jean-Paul Henry; Anais Dumesnil; Annie Lejeune; Sylvanie Renet; Francesca Golding; Zoubir Djerada; Didier Wecker; Virginie Bolduc; Muriel Bouly; Jerome Roussel; Vincent Richard; Paul Mulder
Journal:  JACC Basic Transl Sci       Date:  2017-08-28

7.  Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes.

Authors:  Lulu Song; Xiaomu Kong; Zhaojun Yang; Jinping Zhang; Wenying Yang; Bo Zhang; Xiaoping Chen; Xin Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-11-05       Impact factor: 3.168

8.  Extension of the Life Span by Acarbose: Is It Mediated by the Gut Microbiota?

Authors:  Baiyun Wu; Jiai Yan; Ju Yang; Yanping Xia; Dan Li; Feng Zhang; Hong Cao
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

9.  Regulation of oxidative stress and cardioprotection in diabetes mellitus.

Authors:  Tetsuya Hayashi; Tatsuhiko Mori; Chika Yamashita; Masatoshi Miyamura
Journal:  Curr Cardiol Rev       Date:  2008-11

10.  Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset.

Authors:  Elizabeth Fernandez; Corinna Ross; Hanyu Liang; Martin Javors; Suzette Tardif; Adam B Salmon
Journal:  Pathobiol Aging Age Relat Dis       Date:  2019-08-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.